Stock index futures signal gains; Amylin eyed

PARIS (Reuters) – Stock index futures pointed to a higher open on Wall Street on Monday, with futures for the S&P 500 up 0.29 percent, Dow Jones futures up 0.31 percent and Nasdaq 100 futures up 0.3 percent at 5 a.m. EDT. Bristol-Myers Squibb Co will buy biotechnology company Amylin Pharmaceuticals Inc for about $ 5.3 billion in cash, helping Bristol-Myers extend its portfolio of diabetes treatments with the addition of drugs Byetta and Bydureon. Shares in Amylin traded in Frankfurt were up 6.6 percent. German industrial gas producer Linde AG said on Sunday it has agreed to pay $ 4. …

Stock index futures signal gains; Amylin eyed PARIS (Reuters) – Stock index futures pointed to a higher open on Wall Street on Monday, with futures for the S&P 500 up 0.29 percent, Dow Jones futures up 0.31 percent and Nasdaq 100 futures up 0.3 percent at 5 a.m. EDT. Bristol-Myers Squibb Co will buy biotechnology [...]